NCT01032499View on ClinicalTrials.gov

Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir

PHASE3UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions
Acne Vulgaris II or III DegreeBoils
Interventions
DRUG

oxytetracycline, taro elixir

comparison of treatment efficacy between oxytetracycline and taro elixir

DRUG

Taro Elixir

Taken orally one tablespoon (15 mL) of Taro Elixir 3 times daily for breakfast, lunch and dinner.

Trial Locations (4)

08780070

Policlínica de Mogi das Cruzes, Mogi das Cruzes

09060650

Faculdade de Medicina do ABC, Santo André

03066030

Alergoclínica - Centro de alergia e dermatologia, São Paulo

04505000

Alergoclínica - Centro de alergia e dermatologia, São Paulo

Sponsors
All Listed Sponsors
lead

Laboratorios Goulart S.A.

INDUSTRY